Compare OESX & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | ONCY |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Building Products | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.4M | 109.1M |
| IPO Year | 2007 | 2002 |
| Metric | OESX | ONCY |
|---|---|---|
| Price | $22.13 | $0.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $17.50 | $7.33 |
| AVG Volume (30 Days) | 119.6K | ★ 596.3K |
| Earning Date | 02-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $86,306,000.00 | N/A |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | $2,505.00 |
| P/E Ratio | $47.28 | ★ N/A |
| Revenue Growth | ★ 8.26 | N/A |
| 52 Week Low | $7.08 | $0.73 |
| 52 Week High | $27.37 | $1.51 |
| Indicator | OESX | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 63.55 | 57.13 |
| Support Level | $8.98 | $0.85 |
| Resistance Level | N/A | $1.08 |
| Average True Range (ATR) | 1.87 | 0.04 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 52.63 | 100.00 |
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.